The effect of sildenafil on the pulmonary artery hypertension caused by mustard gas

Journal of Isfahan Medical School

Volumn 26, Issue 90, 2008, Pages

  Tavakolipour, Parya ^a   Sadeghi, Masoomeh ^a   Heidari, Ramin ^a   Vosough, Ali Akbar ^a   Rabiei, Katayoun ^b  

^a ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b Isfahan University of Medical Sciences ^*  (Iran)

Author keywords

Mustard gas poisoning; Pulmonary artery hypertension (PAH); Sildenafil

Indexed keywords

MUSTARD GAS; SILDENAFIL;

ADULT; ARTICLE; CLINICAL ARTICLE; GAS POISONING; HUMAN; LUNG ARTERY PRESSURE; MALE; PULMONARY HYPERTENSION; QUASI EXPERIMENTAL STUDY; SIX MINUTE WALK TEST; TRANSTHORACIC ECHOCARDIOGRAPHY;

EID: 84877786002     PISSN: 10277595     EISSN: 1735854X     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Simonneau G, Galie N, Rubin LJ, Langleben D, Seeger W, Domenighetti G, et al. Clinical classification of pulmonary hypertension. J Am Coll Cardiol 2004; 43(12 Suppl S):5S-12S.
2. Rubin LJ. Primary pulmonary hypertension. N Engl J Med 1997; 336(2):111-7.
3. Sun XG, Hansen JE, Oudiz RJ, Wasserman K. Exercise pathophysiology in patients with primary pulmonary hypertension. Circulation 2001; 104(4):429-35.
4. Galie N, Seeger W, Naeije R, Simonneau G, Rubin LJ. Comparative analysis of clinical trials and evidence-based treatment algorithm in pulmonary arterial hypertension. J Am Coll Cardiol 2004; 43(12 Suppl S):81S-88S.
5. Humbert M, Sitbon O, Simonneau G. Treatment of pulmonary arterial hypertension. N Engl J Med 2004; 351(14):1425-36.
6. Oudiz RJ, Roveran G, Hansen JE, Sun XG, Wasserman K. Effect of sildenafil on ventilatory efficiency and exercise tolerance in pulmonary hypertension. Eur J Heart Fail 2007; 9(9):917-21.
7. Distribution of phosphodiesterase type 5 (PDE5) and effect of its inhibition in chronic hypoxic rat lung.: 2008.
8. Michelakis E, Tymchak W, Lien D, Webster L, Hashimoto K, Archer S. Oral sildenafil is an effective and specific pulmonary vasodilator in patients with pulmonary arterial hypertension: comparison with inhaled nitric oxide. Circulation 2002; 105(20):2398-403.
9. Hefazi M, Attaran D, Mahmoudi M, Balali- Mood M. Late respiratory complications of mustard gas poisoning in Iranian veterans. Inhal Toxicol 2005; 17(11):587-92.
10. Wong RC, Koh GM, Choong PH, Yip WL. Oral sildenafil therapy improves health-related quality of life and functional status in pulmonary arterial hypertension. Int J Cardiol 2007; 119(3):400-2.
11. Michelakis ED, Tymchak W, Noga M, Webster L, Wu XC, Lien D, et al. Long-term treatment with oral sildenafil is safe and improves functional capacity and hemodynamics in patients with pulmonary arterial hypertension. Circulation 2003; 108(17):2066-9.
12. Corbin JD, Francis SH. Cyclic GMP phosphodiesterase- 5: target of sildenafil. J Biol Chem 1999; 274(20):13729-32.
13. Sanchez LS, de la Monte SM, Filippov G, Jones RC, Zapol WM, Bloch KD. Cyclic-GMPbinding, cyclic-GMP-specific phosphodiesterase (PDE5) gene expression is regulated during rat pulmonary development. Pediatr Res 1998; 43(2):163-8.
14. Garg N, Sharma MK, Sinha N. Role of oral sildenafil in severe pulmonary arterial hypertension: clinical efficacy and dose response relationship. Int J Cardiol 2007; 120(3):306-13.
15. van Wolferen SA, Boonstra A, Marcus JT, Marques KM, Bronzwaer JG, Postmus PE, et al. Right ventricular reverse remodelling after sildenafil in pulmonary arterial hypertension. Heart 2006; 92(12):1860-1.
16. Singh TP, Rohit M, Grover A, Malhotra S, Vijayvergiya R. A randomized, placebo-controlled, double-blind, crossover study to evaluate the efficacy of oral sildenafil therapy in severe pulmonary artery hypertension. Am Heart J 2006; 151(4):851-5.
17. Galie N, Ghofrani HA, Torbicki A, Barst RJ, Rubin LJ, Badesch D et al. Sildenafil citrate therapy for pulmonary arterial hypertension. N Engl J Med 2005; 353(20):2148-57.
18. Ghanei M, Adibi I. Clinical Review of Mustard Lung. Iran J Med Sci 2007; 32(2):58-65.
19. Eardley L, Ellis P, Bootell M, Wulff M. Onset and duration of action of sildenafil citrate for the treatment of erectile dysfunction. Br J Clin Pharmacol 2000; 53:61S-65S.